Webinar

Ask Advarra Live: The Real-World Impact of COVID-19 on Research

The unprecedented COVID-19 pandemic has quickly changed how we live and work. This extraordinary situation has resulted in a significant impact on IRB-approved protocols and research yet to go through…

Webinar

Evaluating Payment to Participate in Research: Ethical and Regulatory Issues

March 31, 2020

Luke Gelinas, IRB Chairperson at Advarra, proposes a practical framework for evaluating offers of payment and applies it to case studies to yield guidance on challenging ethical and regulatory issues…

Webinar

Reefer Sanity: IRB Review That Won’t Vaporize Cannabis Protocols

Cannabis and cannabis-derived products are being used with increasing frequency in both recreational and therapeutic settings. With more widespread use of cannabis, how can data from well-designed clinical research trials…

Webinar

Conducting Planned Emergency Research in the Era of sIRB

Planned emergency research (subject to the 21 CFR 50.24 regulations) is challenging for IRBs to review under any circumstance. Now, in the era of single IRB (sIRB), add in the…

Webinar

Preparing for Multisite Gene Therapy Studies

The fast and dramatic growth in the field of gene therapy is unprecedented, as the US FDA and regulatory agencies of several other countries have begun issuing approvals for licensed…

Webinar

Making Mobile Clinical Trials a Reality

New technologies and related methodologies could offer clinical research professionals expanded capacity for low-cost, efficient, and expansive collection of high-quality participant data—both within and beyond the clinical setting. The Clinical…

Webinar

How to Engage Your IRB to Improve Clinical Trial Risk Management

IRBs are in a unique position to impact risk management in clinical research. Their role is designed to protect research participants, but this can also equate to elevating best practices…

Webinar

Real-World Evidence:
What Researchers Must Know

Experts Rebecca Miksad and Tim Stoddard of Flatiron Health provide a practical look at the role of real-world evidence (RWE) in regulatory, drug development, and clinical decision-making.

Webinar

CANCELLED – After the Compliance Date: Revised Common Rule FAQs

February 28, 2019

In this webinar, Michele Russell-Einhorn, JD, Advarra's CCO and IO, and Judith Carrithers, JD, Advarra's Director of Regulatory Affairs, discuss FAQs and common issues in implementing the revised Common Rule.

Webinar

Preparing for and Responding to an FDA Inspection

January 31, 2019

Robert Romanchuk, IRB Chair at Advarra, and Ellen Liedel-Sargent, Senior Director of Consulting at Advarra, outline key activities that can help prepare a research site for a positive inspection experience.…